Most human malignancies are caused by somatic alterations within the
cancer genome, leading to oncogene activation or tumor suppressor
gene inactivation. The sequence of the human genome has enabled systematic
approaches to identify cancer genome alterations, including point
mutations, copy number increases and decreases, loss of allelic heterozygosity,
and chromosome translocations. Systematic cancer genome analysis
has recently led to the discovery of somatic mutations in the BRAF,
PIK3CA, and EGFR genes, among others. With further development of
targeted cancer therapies and improvement in genome analysis technology,
genome-wide surveys of cancer will likely become tools for diagnosis
as well as discovery.
%0 Journal Article
%1 Can
%A Weir, Barbara
%A Zhao, Xiaojun
%A Meyerson, Matthew
%D 2004
%J Cancer Cell
%K Base_Sequence Chromosome_Aberrations Genes,_Tumor_Suppressor Genome,_Human Humans Multigene_Family Mutation Neoplasms,_genetics generalScience
%N 5
%P 433-8
%R 10.1016/j.ccr.2004.11.004
%T Somatic alterations in the human cancer genome.
%U http://dx.doi.org/10.1016/j.ccr.2004.11.004
%V 6
%X Most human malignancies are caused by somatic alterations within the
cancer genome, leading to oncogene activation or tumor suppressor
gene inactivation. The sequence of the human genome has enabled systematic
approaches to identify cancer genome alterations, including point
mutations, copy number increases and decreases, loss of allelic heterozygosity,
and chromosome translocations. Systematic cancer genome analysis
has recently led to the discovery of somatic mutations in the BRAF,
PIK3CA, and EGFR genes, among others. With further development of
targeted cancer therapies and improvement in genome analysis technology,
genome-wide surveys of cancer will likely become tools for diagnosis
as well as discovery.
@article{Can,
abstract = {Most human malignancies are caused by somatic alterations within the
cancer genome, leading to oncogene activation or tumor suppressor
gene inactivation. The sequence of the human genome has enabled systematic
approaches to identify cancer genome alterations, including point
mutations, copy number increases and decreases, loss of allelic heterozygosity,
and chromosome translocations. Systematic cancer genome analysis
has recently led to the discovery of somatic mutations in the BRAF,
PIK3CA, and EGFR genes, among others. With further development of
targeted cancer therapies and improvement in genome analysis technology,
genome-wide surveys of cancer will likely become tools for diagnosis
as well as discovery.},
added-at = {2010-01-26T20:35:53.000+0100},
author = {Weir, Barbara and Zhao, Xiaojun and Meyerson, Matthew},
biburl = {https://www.bibsonomy.org/bibtex/23a6ce53be49e7f8eaf9e648f3fe3940e/denilw},
doi = {10.1016/j.ccr.2004.11.004},
file = {article:../Cancer/Somatic alterations in the human cancer genome.pdf:pdf},
institution = {Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard
Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.},
interhash = {e54813338c8c40add9f26adb92957b0f},
intrahash = {3a6ce53be49e7f8eaf9e648f3fe3940e},
journal = {Cancer Cell},
keywords = {Base_Sequence Chromosome_Aberrations Genes,_Tumor_Suppressor Genome,_Human Humans Multigene_Family Mutation Neoplasms,_genetics generalScience},
month = Nov,
number = 5,
owner = {denilw},
pages = {433-8},
pii = {S1535610804003186},
pmid = {15542426},
timestamp = {2010-01-26T20:36:04.000+0100},
title = {Somatic alterations in the human cancer genome.},
url = {http://dx.doi.org/10.1016/j.ccr.2004.11.004},
volume = 6,
year = 2004
}